查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1688875

日本的精液分析市場:預測(2025年～2032年)

Japan Semen Analysis Market Forecast 2025-2032
出版日期: | 出版商: Inkwood Research | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

預計在 2025 年至 2032 年的預測期內，日本精液分析市場規模將以 6.61% 的複合年增長率成長。預計 2024 年市場規模將達到 6,085 萬美元，到 2032 年將達到 1.0179 億美元。

隨著人們對不孕症認識的不斷提高、診斷技術的進步以及不孕症治療診所和 ART 中心的擴張，日本的精液分析市場預計將會成長。

對家用精液分析試劑盒等便利、私密的診斷解決方案的需求不斷增長將進一步推動市場成長。然而，社會文化恥辱、男性生殖健康意識低落以及醫療保健成本高等課題可能會阻礙市場成長。

在日本，很大一部分不孕症是由男性因素造成的，歷史上約佔24%。夫妻中不孕症治療十分普遍，約有 18.2% 的夫妻尋求協助。這反映出人們對男性不孕症的先進診斷工具和生育治療解決方案的需求日益增長。

此外，日本面臨嚴重的人口課題，近年來男性總生育率從 1.92 下降到 1.17。到2020年，日本女性生育率預計也將降至每名婦女1.4個孩子以下，凸顯了解決日本生殖健康問題的迫切性。

吸菸、糖尿病等生活習慣對日本男性的生育率有顯著影響。預計2022年，日本的菸草使用者人數將達到1,860萬人，成為全球第十大菸草消費國。

吸菸與精液品質差有關，13.5% 的人口患有第 2 型糖尿病或糖耐量受損。這些因素凸顯了對可獲得且有效的男性不孕症診斷的迫切需求。

包括人工智慧驅動的創新在內的技術進步正在改變日本的精液分析市場。此人工智慧工具可以準確評估精子數量、活力和形態等關鍵參數，為臨床和家庭環境提供可靠的解決方案。 CASA系統和先進影像技術的採用進一步提高了診斷的準確性和效率。

本報告提供日本的按精液分析市場相關調查，彙整市場概要，以及各診斷技術，檢測套組·試劑，各年齡層，各終端用戶趨勢，競爭情形等資料。

目錄

第1章 調查範圍和調查手法

第2章 摘要整理

第3章 市場動態

  • 主要的促進因素
  • 主要的阻礙因素

第4章 主要分析

  • 親市場分析
  • 主要的市場趨勢
  • 大環境分析
  • 波特的五力分析
  • 成長預測製圖
  • 市場成熟度分析
  • 市場集中分析
  • 價值鏈分析
  • 主要的購買標準
  • 法規結構

第5章 各診斷技術市場分析

  • 顯微鏡檢驗
  • 電腦支援精液分析(CASA)
  • 其他的診斷技術

第6章 檢測套組·試劑市場

  • 檢測套組與消耗品
  • 試劑和培養基

第7章 各年齡層市場

  • 34歲以下
  • 35～40歲
  • 41歲以上

第8章 各終端用戶市場

  • 醫院
  • 不孕治療中心
  • 診斷檢驗室
  • 其他

第9章 競爭情形

  • 主要的策略性展開
  • 企業簡介
    • BIOMERIEUX SA
    • COOPER COMPANIES INC
    • DITECT CO LTD
    • DNA DIAGNOSTICS CENTER
    • HAMILTON THORNE INC
    • LEJA PRODUCTS BV
    • MEDICAL ELECTRONIC SYSTEMS INC
    • OPTOSCOPIA
Product Code: 103076

KEY FINDINGS

The Japan semen analysis market is predicted to grow with a CAGR of 6.61% over the forecast period 2025-2032. The market was valued at $60.85 million in 2024 and is expected to reach a revenue of $101.79 million by 2032.

The Japan semen analysis market is set to grow, driven by increasing awareness of infertility, advancements in diagnostic technologies, and the expansion of fertility clinics and ART centers.

Rising demand for convenient and private diagnostic solutions, including at-home semen analysis kits, further supports market growth. However, challenges such as sociocultural stigmas, limited awareness of male reproductive health, and high healthcare costs may hinder progress.

MARKET INSIGHTS

A significant percentage of infertility cases in Japan are attributed to male factors, accounting for approximately 24% of cases historically. Infertility treatment among couples is prevalent, with around 18.2% seeking assistance. This reflects the growing need for advanced diagnostic tools and fertility solutions tailored to address male infertility.

Additionally, Japan faces deep-rooted demographic challenges, with the total fertility rate among men declining from 1.92 to 1.17 over recent years. By 2020, the fertility rate for women had also dropped below 1.4 children per woman, highlighting the urgency of addressing reproductive health issues in the nation.

Lifestyle factors such as smoking and diabetes significantly impact male fertility in Japan. An estimated 18.6 million individuals in Japan were tobacco users in 2022, ranking the country as the 10th globally in tobacco consumption.

Smoking has been linked to reduced semen quality, while 13.5% of the population suffers from type 2 diabetes or impaired glucose tolerance, conditions known to adversely affect sperm quality and quantity. These factors highlight the critical need for accessible and effective male fertility diagnostics.

Technological advancements, including AI-driven innovations, are transforming the semen analysis market in Japan. AI-powered tools provide precise assessments of key sperm parameters, such as count, motility, and morphology, offering reliable solutions in both clinical and home-based settings. The adoption of CASA systems and advanced imaging techniques is further enhancing diagnostic accuracy and efficiency.

SEGMENTATION ANALYSIS

The Japan semen analysis market is segmented into diagnostic technique, testing kits and reagents, age group, and end-user. The diagnostic technique category is further classified into microscopic examination, computer-assisted semen analysis (CASA), and other diagnostic techniques.

CASA systems are gaining traction in fertility clinics and laboratories for their ability to deliver automated and consistent analyses. The rising demand for at-home testing kits reflects a shift toward patient-centered solutions, driven by convenience and privacy.

On the other hand, microscopic examination remains a widely used method for semen analysis in clinical settings, valued for its cost-effectiveness and ability to meet fundamental diagnostic needs.

However, advanced technologies, particularly those integrating AI, are increasingly being adopted to address limitations in traditional techniques and to provide standardized results. These innovations align with the growing demand for accurate and accessible diagnostics.

With a high prevalence of male infertility, lifestyle-related health conditions, and demographic challenges, the demand for advanced reproductive health solutions in Japan is expected to rise. Addressing barriers to awareness and accessibility, alongside the continued integration of innovative technologies, positions Japan as a key market for the development of semen analysis and fertility diagnostics.

COMPETITIVE INSIGHTS

Some of the leading players in the Japan semen analysis market include bioMerieux SA, Optoscopia, Ditect Co Ltd, DNA Diagnostics Center, Hamilton Thorne Inc, etc.

Optoscopia is a leading manufacturer of computer-aided semen analysis (CASA) systems, specializing in the integration of optical technology and artificial intelligence (AI) to meticulously examine sperm samples.

The company's flagship products, the SIA Lab and SIA Lab Plus are designed to process semen samples with high accuracy, assessing essential parameters related to sperm quality, including motility, concentration, vitality, morphology, leukocyte presence, and DNA fragmentation. The company operates through 2 primary locations in Spain and Tunisia.

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. SCOPE OF STUDY
  • 2.5. CRISIS SCENARIO ANALYSIS
  • 2.6. MAJOR MARKET FINDINGS
    • 2.6.1. INCREASING PREFERENCE FOR HOME SEMEN ANALYSIS KITS DUE TO CONVENIENCE AND PRIVACY
    • 2.6.2. INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF MALE INFERTILITY IN JAPAN
    • 3.1.2. ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES
    • 3.1.3. EXPANSION OF FERTILITY CLINICS AND ART CENTERS
    • 3.1.4. GROWING AWARENESS OF REPRODUCTIVE HEALTH
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COSTS OF ADVANCED DIAGNOSTIC PROCEDURES
    • 3.2.2. SOCIOCULTURAL STIGMAS ASSOCIATED WITH MALE INFERTILITY
    • 3.2.3. INCONSISTENT INSURANCE COVERAGE AND REIMBURSEMENT POLICIES

4. KEY ANALYTICS

  • 4.1. PARENT MARKET ANALYSIS
  • 4.2. KEY MARKET TRENDS
    • 4.2.1. INCREASING DEMAND FOR CONVENIENT AND PRIVATE HOME-BASED SEMEN TESTING KITS
  • 4.3. PESTLE ANALYSIS
    • 4.3.1. POLITICAL
    • 4.3.2. ECONOMICAL
    • 4.3.3. SOCIAL
    • 4.3.4. TECHNOLOGICAL
    • 4.3.5. LEGAL
    • 4.3.6. ENVIRONMENTAL
  • 4.4. PORTER'S FIVE FORCES ANALYSIS
    • 4.4.1. BUYERS POWER
    • 4.4.2. SUPPLIERS POWER
    • 4.4.3. SUBSTITUTION
    • 4.4.4. NEW ENTRANTS
    • 4.4.5. INDUSTRY RIVALRY
  • 4.5. GROWTH PROSPECT MAPPING
    • 4.5.1. GROWTH PROSPECT MAPPING FOR JAPAN
  • 4.6. MARKET MATURITY ANALYSIS
  • 4.7. MARKET CONCENTRATION ANALYSIS
  • 4.8. VALUE CHAIN ANALYSIS
    • 4.8.1. EQUIPMENT AND REAGENT MANUFACTURERS
    • 4.8.2. DISTRIBUTORS AND SUPPLIERS
    • 4.8.3. SERVICE PROVIDERS
    • 4.8.4. END-USER
  • 4.9. KEY BUYING CRITERIA
    • 4.9.1. ACCURACY AND RELIABILITY
    • 4.9.2. EASE OF USE
    • 4.9.3. COST
    • 4.9.4. TURNAROUND TIME
    • 4.9.5. PORTABILITY AND CONVENIENCE
  • 4.10. REGULATORY FRAMEWORK

5. MARKET BY DIAGNOSTIC TECHNIQUE

  • 5.1. MICROSCOPIC EXAMINATION
    • 5.1.1. MARKET FORECAST FIGURE
    • 5.1.2. SEGMENT ANALYSIS
  • 5.2. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
    • 5.2.1. MARKET FORECAST FIGURE
    • 5.2.2. SEGMENT ANALYSIS
  • 5.3. OTHER DIAGNOSTIC TECHNIQUES
    • 5.3.1. MARKET FORECAST FIGURE
    • 5.3.2. SEGMENT ANALYSIS

6. MARKET BY TESTING KITS AND REAGENTS

  • 6.1. TESTING KITS AND CONSUMABLES
    • 6.1.1. MARKET FORECAST FIGURE
    • 6.1.2. SEGMENT ANALYSIS
  • 6.2. REAGENTS AND MEDIA
    • 6.2.1. MARKET FORECAST FIGURE
    • 6.2.2. SEGMENT ANALYSIS

7. MARKET BY AGE GROUP

  • 7.1. 34 YEARS AND BELOW
    • 7.1.1. MARKET FORECAST FIGURE
    • 7.1.2. SEGMENT ANALYSIS
  • 7.2. 35-40 YEARS
    • 7.2.1. MARKET FORECAST FIGURE
    • 7.2.2. SEGMENT ANALYSIS
  • 7.3. 41 YEARS AND ABOVE
    • 7.3.1. MARKET FORECAST FIGURE
    • 7.3.2. SEGMENT ANALYSIS

8. MARKET BY END-USER

  • 8.1. HOSPITALS
    • 8.1.1. MARKET FORECAST FIGURE
    • 8.1.2. SEGMENT ANALYSIS
  • 8.2. FERTILITY CENTERS
    • 8.2.1. MARKET FORECAST FIGURE
    • 8.2.2. SEGMENT ANALYSIS
  • 8.3. DIAGNOSTIC LABORATORIES
    • 8.3.1. MARKET FORECAST FIGURE
    • 8.3.2. SEGMENT ANALYSIS
  • 8.4. OTHER END-USERS
    • 8.4.1. MARKET FORECAST FIGURE
    • 8.4.2. SEGMENT ANALYSIS

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. BUSINESS EXPANSIONS AND DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. BIOMERIEUX SA
      • 9.2.1.1. COMPANY OVERVIEW
      • 9.2.1.2. PRODUCTS
      • 9.2.1.3. STRENGTHS & CHALLENGES
    • 9.2.2. COOPER COMPANIES INC
      • 9.2.2.1. COMPANY OVERVIEW
      • 9.2.2.2. PRODUCTS
      • 9.2.2.3. STRENGTHS & CHALLENGES
    • 9.2.3. DITECT CO LTD
      • 9.2.3.1. COMPANY OVERVIEW
      • 9.2.3.2. PRODUCTS
      • 9.2.3.3. STRENGTHS & CHALLENGES
    • 9.2.4. DNA DIAGNOSTICS CENTER
      • 9.2.4.1. COMPANY OVERVIEW
      • 9.2.4.2. PRODUCTS
      • 9.2.4.3. STRENGTHS & CHALLENGES
    • 9.2.5. HAMILTON THORNE INC
      • 9.2.5.1. COMPANY OVERVIEW
      • 9.2.5.2. PRODUCTS
      • 9.2.5.3. STRENGTHS & CHALLENGES
    • 9.2.6. LEJA PRODUCTS BV
      • 9.2.6.1. COMPANY OVERVIEW
      • 9.2.6.2. PRODUCTS
      • 9.2.6.3. STRENGTHS & CHALLENGES
    • 9.2.7. MEDICAL ELECTRONIC SYSTEMS INC
      • 9.2.7.1. COMPANY OVERVIEW
      • 9.2.7.2. PRODUCTS
      • 9.2.7.3. STRENGTHS & CHALLENGES
    • 9.2.8. OPTOSCOPIA
      • 9.2.8.1. COMPANY OVERVIEW
      • 9.2.8.2. PRODUCTS
      • 9.2.8.3. STRENGTHS & CHALLENGES

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SEMEN ANALYSIS
  • TABLE 2: REGULATORY FRAMEWORK
  • TABLE 3: JAPAN SEMEN ANALYSIS MARKET, BY DIAGNOSTIC TECHNIQUE, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 4: JAPAN SEMEN ANALYSIS MARKET, BY DIAGNOSTIC TECHNIQUE, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 5: JAPAN SEMEN ANALYSIS MARKET, BY TESTING KITS AND REAGENTS, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 6: JAPAN SEMEN ANALYSIS MARKET, BY TESTING KITS AND REAGENTS, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 7: JAPAN SEMEN ANALYSIS MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 8: JAPAN SEMEN ANALYSIS MARKET, BY AGE GROUP, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 9: JAPAN SEMEN ANALYSIS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 10: JAPAN SEMEN ANALYSIS MARKET, BY END-USER, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 11: LIST OF MERGERS & ACQUISITIONS
  • TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 14: LIST OF BUSINESS EXPANSIONS AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN
  • FIGURE 4: MARKET MATURITY ANALYSIS
  • FIGURE 5: MARKET CONCENTRATION ANALYSIS
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: KEY BUYING CRITERIA
  • FIGURE 8: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY DIAGNOSTIC TECHNIQUE, IN 2024
  • FIGURE 9: JAPAN SEMEN ANALYSIS MARKET, BY MICROSCOPIC EXAMINATION, 2025-2032 (IN $ MILLION)
  • FIGURE 10: JAPAN SEMEN ANALYSIS MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2025-2032 (IN $ MILLION)
  • FIGURE 11: JAPAN SEMEN ANALYSIS MARKET, BY OTHER DIAGNOSTIC TECHNIQUES, 2025-2032 (IN $ MILLION)
  • FIGURE 12: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY TESTING KITS AND REAGENTS, IN 2024
  • FIGURE 13: JAPAN SEMEN ANALYSIS MARKET, BY TESTING KITS AND CONSUMABLES, 2025-2032 (IN $ MILLION)
  • FIGURE 14: JAPAN SEMEN ANALYSIS MARKET, BY REAGENTS AND MEDIA, 2025-2032 (IN $ MILLION)
  • FIGURE 15: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2024
  • FIGURE 16: JAPAN SEMEN ANALYSIS MARKET, BY 34 YEARS AND BELOW, 2025-2032 (IN $ MILLION)
  • FIGURE 17: JAPAN SEMEN ANALYSIS MARKET, BY 35-40 YEARS, 2025-2032 (IN $ MILLION)
  • FIGURE 18: JAPAN SEMEN ANALYSIS MARKET, BY 41 YEARS AND ABOVE, 2025-2032 (IN $ MILLION)
  • FIGURE 19: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2024
  • FIGURE 20: JAPAN SEMEN ANALYSIS MARKET, BY HOSPITALS, 2025-2032 (IN $ MILLION)
  • FIGURE 21: JAPAN SEMEN ANALYSIS MARKET, BY FERTILITY CENTERS, 2025-2032 (IN $ MILLION)
  • FIGURE 22: JAPAN SEMEN ANALYSIS MARKET, BY DIAGNOSTIC LABORATORIES, 2025-2032 (IN $ MILLION)
  • FIGURE 23: JAPAN SEMEN ANALYSIS MARKET, BY OTHER END-USERS, 2025-2032 (IN $ MILLION)